1450642-92-8
1450642-92-8 structure
- Name: Cemdomespib
- Chemical Name: Cemdomespib
- CAS Number: 1450642-92-8
- Molecular Formula: C24H30FNO6
- Molecular Weight: 447.50
- Catalog: Signaling Pathways Cell Cycle/DNA Damage HSP
- Create Date: 2022-03-23 11:37:29
- Modify Date: 2024-01-09 14:57:53
-
Cemdomespib (KU-596) is a highly bioavailable second-generation Hsp90 modulator. Cemdomespib has shown efficacy in improving sensory deficits in models of diabetic peripheral neuropathy. Cemdomespib induces Hsp70 levels and manifest neuroprotective activity through induction of the heat shock response[1][2][3].
| Name | Cemdomespib |
|---|
| Description | Cemdomespib (KU-596) is a highly bioavailable second-generation Hsp90 modulator. Cemdomespib has shown efficacy in improving sensory deficits in models of diabetic peripheral neuropathy. Cemdomespib induces Hsp70 levels and manifest neuroprotective activity through induction of the heat shock response[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
HSP90 |
| In Vivo | After 8 weeks of diabetes, Cemdomespib (KU-596; 2, 10, or 20 mg/kg ; i.p.; administered for 6 weeks via a once per week) dose-dependently reverses the pre-existing psychosensory deficits. Cemdomespib also dose-dependently prevents the diabetes-induced deficits in motor (MNCV) and sensory (SNCV) nerve conduction velocities[1]. Cemdomespib (20 mg/kg; oral gavage once per week for 4 weeks) significantly reverses the sensory hypoalgesia in WT mice but not the Hsp70 KO mice[1]. Animal Model: Diabetic Swiss Webster mice [1] Dosage: 2, 10, or 20 mg/kg Administration: Administered after 8 weeks of diabetes via once per week intra-peritoneal injections. Result: Improved diabetes induced hypoalgesia and sensory neuron bioenergetic deficits in a dose-dependent manner. |
| References |
| Molecular Formula | C24H30FNO6 |
|---|---|
| Molecular Weight | 447.50 |